First-quarter results of pharma bigwigs like Pfizer PFE, Merck MRK and Allergan AGN stole the limelight this week. Other than that, Novartis NVS gained FDA approval for the second indication of its CAR-T therapy, Kymriah. While AbbVie …
Shares of Merck & Co (NYSE:MRK) have bullishly opened above the pivot of $60.10 ... price of $60.75 and an average consensus analyst price target of $66.33. The stock should discover initial support at its 50-day moving average (MA) of …
May 1 Drugmaker Merck & Co posted a 52.5 percent fall in first-quarter profit on Tuesday, hurt by hefty charge related to its collaboration with Eisai Co Ltd.
Alethea Capital Management Llc decreased Merck & Co Inc (MRK) stake by 50% reported in 2017Q3 SEC filing. …
Last week, U.S. Senator Tina Smith expressed concerns that big pharma companies plan to use their large corporate tax savings to reward shareholders instead of bringing down costs of expensive drugs and benefiting consumers. The …